{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-033749","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2026-08-19T20:52:07+00:00","discovered_at":"2026-08-19T20:53:01.345684+00:00","generated_at":"2026-08-19T20:53:10.059445+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PDS Biotech CFO Lars Boesgaard resigns; interim CFO and PIO appointed","bullets":["Lars Boesgaard resigns as CFO, PFO and PAO effective Sept 12, 2026, to pursue other professional endeavors.","Resignation is not due to any disagreement with Company operations, policies or practices.","Frank Bedu-Addo, Ph.D. (President & CEO) appointed interim Principal Financial Officer, effective Sept 12, 2026.","Janetta Trochimiuk (Controller) appointed interim Principal Accounting Officer; salary $279,519.57/yr, no new equity awards.","Trochimiuk has 25+ years as Controller/CFO; prior Controller at Delcath Systems and other firms."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-033749","json":"https://secwatch.observer/filing/0001140361-26-033749.json","markdown":"https://secwatch.observer/filing/0001140361-26-033749.md","text":"https://secwatch.observer/filing/0001140361-26-033749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/ef20080681_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-19T20:53:10.059445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6aecd5fdf4","claim":"Janetta Trochimiuk was appointed as Principal Accounting Officer at PDS Biotechnology Corp.","evidence_excerpt":"On August 19, 2026, the board of directors of the Company appointed Janetta Trochimiuk, the Company’s Controller, as interim Principal Accounting Officer and Frank Bedu-Addo, Ph.D., the Company’s President and Chief Executive Officer, as interim Principal Financial Officer, each effective as of September 12, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"ce88efbc7a","claim":"Frank Bedu-Addo was appointed as Principal Financial Officer at PDS Biotechnology Corp.","evidence_excerpt":"On August 19, 2026, the board of directors of the Company appointed Janetta Trochimiuk, the Company’s Controller, as interim Principal Accounting Officer and Frank Bedu-Addo, Ph.D., the Company’s President and Chief Executive Officer, as interim Principal Financial Officer, each effective as of September 12, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"d457720131","claim":"Lars Boesgaard resigned as Chief Financial Officer at PDS Biotechnology Corp.","evidence_excerpt":"On August 13, 2026, Lars Boesgaard submitted his resignation, effective as of September 12, 2026, as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of PDS Biotechnology Corporation (the “ Company ”) in order to pursue other professional endeavors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126033749/0001140361-26-033749-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}